nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—AKR1C3—Doxorubicin—sarcoma	0.434	0.643	CbGbCtD
Mefenamic acid—PTGS2—Etoposide—sarcoma	0.103	0.153	CbGbCtD
Mefenamic acid—PTGS1—Etoposide—sarcoma	0.0872	0.129	CbGbCtD
Mefenamic acid—CYP2C8—Etoposide—sarcoma	0.0503	0.0746	CbGbCtD
Mefenamic acid—AKR1C3—Podofilox—Etoposide—sarcoma	0.00492	0.592	CbGdCrCtD
Mefenamic acid—PTGS2—periosteum—sarcoma	0.0047	0.0625	CbGeAlD
Mefenamic acid—AKR1C2—testis—sarcoma	0.00441	0.0588	CbGeAlD
Mefenamic acid—AKR1C2—liver—sarcoma	0.00417	0.0556	CbGeAlD
Mefenamic acid—PTGS2—leg—sarcoma	0.00374	0.0498	CbGeAlD
Mefenamic acid—AKR1C3—Vinblastine—Vincristine—sarcoma	0.00339	0.408	CbGdCrCtD
Mefenamic acid—PTGS2—hindlimb—sarcoma	0.00334	0.0445	CbGeAlD
Mefenamic acid—PTGS2—cartilage tissue—sarcoma	0.00329	0.0438	CbGeAlD
Mefenamic acid—Acetylsalicylic acid—TP53—sarcoma	0.00329	1	CrCbGaD
Mefenamic acid—AKR1C2—lymph node—sarcoma	0.0032	0.0426	CbGeAlD
Mefenamic acid—AKR1C3—myometrium—sarcoma	0.00293	0.039	CbGeAlD
Mefenamic acid—PTGS2—appendage—sarcoma	0.00287	0.0382	CbGeAlD
Mefenamic acid—AKR1C3—seminal vesicle—sarcoma	0.00265	0.0352	CbGeAlD
Mefenamic acid—AKR1C3—smooth muscle tissue—sarcoma	0.00221	0.0295	CbGeAlD
Mefenamic acid—AKR1C3—cardiac atrium—sarcoma	0.00191	0.0254	CbGeAlD
Mefenamic acid—AKR1C3—uterus—sarcoma	0.0019	0.0253	CbGeAlD
Mefenamic acid—PTGS1—endothelium—sarcoma	0.00181	0.0241	CbGeAlD
Mefenamic acid—CYP2C8—mammary gland—sarcoma	0.0018	0.024	CbGeAlD
Mefenamic acid—PTGS2—endothelium—sarcoma	0.00173	0.0231	CbGeAlD
Mefenamic acid—AKR1C3—tendon—sarcoma	0.00166	0.0222	CbGeAlD
Mefenamic acid—AKR1C3—bone marrow—sarcoma	0.00161	0.0215	CbGeAlD
Mefenamic acid—CYP2C9—mammary gland—sarcoma	0.0016	0.0213	CbGeAlD
Mefenamic acid—AKR1C3—testis—sarcoma	0.00138	0.0183	CbGeAlD
Mefenamic acid—AKR1C3—liver—sarcoma	0.0013	0.0173	CbGeAlD
Mefenamic acid—CYP2C8—hematopoietic system—sarcoma	0.0011	0.0146	CbGeAlD
Mefenamic acid—AKR1C3—lymph node—sarcoma	0.000999	0.0133	CbGeAlD
Mefenamic acid—PTGS2—myometrium—sarcoma	0.00099	0.0132	CbGeAlD
Mefenamic acid—CYP2C9—hematopoietic system—sarcoma	0.000974	0.013	CbGeAlD
Mefenamic acid—PTGS2—embryo—sarcoma	0.000952	0.0127	CbGeAlD
Mefenamic acid—PTGS1—seminal vesicle—sarcoma	0.000936	0.0125	CbGeAlD
Mefenamic acid—PTGS2—seminal vesicle—sarcoma	0.000895	0.0119	CbGeAlD
Mefenamic acid—PTGS1—hematopoietic system—sarcoma	0.00089	0.0118	CbGeAlD
Mefenamic acid—PTGS1—connective tissue—sarcoma	0.000857	0.0114	CbGeAlD
Mefenamic acid—PTGS2—hematopoietic system—sarcoma	0.00085	0.0113	CbGeAlD
Mefenamic acid—PTGS2—connective tissue—sarcoma	0.000819	0.0109	CbGeAlD
Mefenamic acid—PTGS1—smooth muscle tissue—sarcoma	0.000784	0.0104	CbGeAlD
Mefenamic acid—PTGS1—skin of body—sarcoma	0.000773	0.0103	CbGeAlD
Mefenamic acid—PTGS2—smooth muscle tissue—sarcoma	0.000749	0.00997	CbGeAlD
Mefenamic acid—PTGS2—skin of body—sarcoma	0.000739	0.00984	CbGeAlD
Mefenamic acid—PTGS1—cardiac atrium—sarcoma	0.000675	0.00899	CbGeAlD
Mefenamic acid—PTGS1—uterus—sarcoma	0.000672	0.00895	CbGeAlD
Mefenamic acid—PTGS2—uterus—sarcoma	0.000642	0.00855	CbGeAlD
Mefenamic acid—CYP2C8—testis—sarcoma	0.000601	0.008	CbGeAlD
Mefenamic acid—PTGS2—lymphoid tissue—sarcoma	0.000599	0.00797	CbGeAlD
Mefenamic acid—PTGS1—tendon—sarcoma	0.000589	0.00784	CbGeAlD
Mefenamic acid—CYP2C8—liver—sarcoma	0.000568	0.00757	CbGeAlD
Mefenamic acid—PTGS2—tendon—sarcoma	0.000563	0.00749	CbGeAlD
Mefenamic acid—PTGS2—bone marrow—sarcoma	0.000545	0.00726	CbGeAlD
Mefenamic acid—CYP2C9—liver—sarcoma	0.000505	0.00672	CbGeAlD
Mefenamic acid—PTGS1—testis—sarcoma	0.000487	0.00649	CbGeAlD
Mefenamic acid—PTGS2—liver—sarcoma	0.000441	0.00587	CbGeAlD
Mefenamic acid—Paraesthesia—Vincristine—sarcoma	0.000415	0.00174	CcSEcCtD
Mefenamic acid—Urticaria—Thiotepa—sarcoma	0.000414	0.00174	CcSEcCtD
Mefenamic acid—Malaise—Etoposide—sarcoma	0.000414	0.00174	CcSEcCtD
Mefenamic acid—Vertigo—Etoposide—sarcoma	0.000413	0.00173	CcSEcCtD
Mefenamic acid—Abdominal pain—Thiotepa—sarcoma	0.000412	0.00173	CcSEcCtD
Mefenamic acid—Body temperature increased—Thiotepa—sarcoma	0.000412	0.00173	CcSEcCtD
Mefenamic acid—Leukopenia—Etoposide—sarcoma	0.000411	0.00173	CcSEcCtD
Mefenamic acid—Purpura—Doxorubicin—sarcoma	0.00041	0.00172	CcSEcCtD
Mefenamic acid—Abdominal pain—Dactinomycin—sarcoma	0.000409	0.00172	CcSEcCtD
Mefenamic acid—Body temperature increased—Dactinomycin—sarcoma	0.000409	0.00172	CcSEcCtD
Mefenamic acid—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000409	0.00172	CcSEcCtD
Mefenamic acid—Paraesthesia—Mitoxantrone—sarcoma	0.000405	0.0017	CcSEcCtD
Mefenamic acid—Loss of consciousness—Etoposide—sarcoma	0.000404	0.00169	CcSEcCtD
Mefenamic acid—Decreased appetite—Vincristine—sarcoma	0.000402	0.00169	CcSEcCtD
Mefenamic acid—Dyspnoea—Mitoxantrone—sarcoma	0.000402	0.00169	CcSEcCtD
Mefenamic acid—Somnolence—Mitoxantrone—sarcoma	0.000401	0.00168	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Vincristine—sarcoma	0.000399	0.00168	CcSEcCtD
Mefenamic acid—Convulsion—Etoposide—sarcoma	0.000398	0.00167	CcSEcCtD
Mefenamic acid—Hyponatraemia—Doxorubicin—sarcoma	0.000397	0.00167	CcSEcCtD
Mefenamic acid—Dyspepsia—Mitoxantrone—sarcoma	0.000397	0.00167	CcSEcCtD
Mefenamic acid—Hypertension—Etoposide—sarcoma	0.000396	0.00166	CcSEcCtD
Mefenamic acid—Constipation—Vincristine—sarcoma	0.000396	0.00166	CcSEcCtD
Mefenamic acid—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000395	0.00166	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Epirubicin—sarcoma	0.000395	0.00166	CcSEcCtD
Mefenamic acid—Decreased appetite—Mitoxantrone—sarcoma	0.000392	0.00164	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000388	0.00163	CcSEcCtD
Mefenamic acid—Discomfort—Etoposide—sarcoma	0.000386	0.00162	CcSEcCtD
Mefenamic acid—Constipation—Mitoxantrone—sarcoma	0.000385	0.00162	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000385	0.00162	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Vincristine—sarcoma	0.000378	0.00159	CcSEcCtD
Mefenamic acid—Gastritis—Epirubicin—sarcoma	0.000378	0.00159	CcSEcCtD
Mefenamic acid—Confusional state—Etoposide—sarcoma	0.000378	0.00159	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Etoposide—sarcoma	0.000375	0.00157	CcSEcCtD
Mefenamic acid—Asthenia—Thiotepa—sarcoma	0.000374	0.00157	CcSEcCtD
Mefenamic acid—Infection—Etoposide—sarcoma	0.000372	0.00156	CcSEcCtD
Mefenamic acid—Asthenia—Dactinomycin—sarcoma	0.000371	0.00156	CcSEcCtD
Mefenamic acid—Feeling abnormal—Mitoxantrone—sarcoma	0.000371	0.00156	CcSEcCtD
Mefenamic acid—Asthma—Epirubicin—sarcoma	0.000369	0.00155	CcSEcCtD
Mefenamic acid—Pruritus—Thiotepa—sarcoma	0.000369	0.00155	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000368	0.00155	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Etoposide—sarcoma	0.000367	0.00154	CcSEcCtD
Mefenamic acid—Tachycardia—Etoposide—sarcoma	0.000366	0.00154	CcSEcCtD
Mefenamic acid—Eosinophilia—Epirubicin—sarcoma	0.000366	0.00154	CcSEcCtD
Mefenamic acid—Body temperature increased—Vincristine—sarcoma	0.000366	0.00154	CcSEcCtD
Mefenamic acid—Abdominal pain—Vincristine—sarcoma	0.000366	0.00154	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Doxorubicin—sarcoma	0.000365	0.00153	CcSEcCtD
Mefenamic acid—Skin disorder—Etoposide—sarcoma	0.000364	0.00153	CcSEcCtD
Mefenamic acid—Pancreatitis—Epirubicin—sarcoma	0.000362	0.00152	CcSEcCtD
Mefenamic acid—Urticaria—Mitoxantrone—sarcoma	0.000358	0.0015	CcSEcCtD
Mefenamic acid—Anorexia—Etoposide—sarcoma	0.000357	0.0015	CcSEcCtD
Mefenamic acid—Diarrhoea—Thiotepa—sarcoma	0.000357	0.0015	CcSEcCtD
Mefenamic acid—Abdominal pain—Mitoxantrone—sarcoma	0.000356	0.0015	CcSEcCtD
Mefenamic acid—Body temperature increased—Mitoxantrone—sarcoma	0.000356	0.0015	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000356	0.0015	CcSEcCtD
Mefenamic acid—Diarrhoea—Dactinomycin—sarcoma	0.000354	0.00149	CcSEcCtD
Mefenamic acid—PTGS1—lymph node—sarcoma	0.000353	0.0047	CbGeAlD
Mefenamic acid—Pancytopenia—Epirubicin—sarcoma	0.000351	0.00147	CcSEcCtD
Mefenamic acid—Hypotension—Etoposide—sarcoma	0.00035	0.00147	CcSEcCtD
Mefenamic acid—Gastritis—Doxorubicin—sarcoma	0.00035	0.00147	CcSEcCtD
Mefenamic acid—Dysuria—Epirubicin—sarcoma	0.000345	0.00145	CcSEcCtD
Mefenamic acid—Dizziness—Thiotepa—sarcoma	0.000345	0.00145	CcSEcCtD
Mefenamic acid—Asthma—Doxorubicin—sarcoma	0.000342	0.00144	CcSEcCtD
Mefenamic acid—Eosinophilia—Doxorubicin—sarcoma	0.000338	0.00142	CcSEcCtD
Mefenamic acid—PTGS2—lymph node—sarcoma	0.000338	0.0045	CbGeAlD
Mefenamic acid—Photosensitivity reaction—Epirubicin—sarcoma	0.000337	0.00142	CcSEcCtD
Mefenamic acid—Paraesthesia—Etoposide—sarcoma	0.000337	0.00141	CcSEcCtD
Mefenamic acid—Pancreatitis—Doxorubicin—sarcoma	0.000335	0.00141	CcSEcCtD
Mefenamic acid—Dyspnoea—Etoposide—sarcoma	0.000334	0.0014	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Epirubicin—sarcoma	0.000333	0.0014	CcSEcCtD
Mefenamic acid—Somnolence—Etoposide—sarcoma	0.000333	0.0014	CcSEcCtD
Mefenamic acid—Asthenia—Vincristine—sarcoma	0.000332	0.00139	CcSEcCtD
Mefenamic acid—Vomiting—Thiotepa—sarcoma	0.000332	0.00139	CcSEcCtD
Mefenamic acid—Pneumonia—Epirubicin—sarcoma	0.000331	0.00139	CcSEcCtD
Mefenamic acid—Drowsiness—Epirubicin—sarcoma	0.000329	0.00138	CcSEcCtD
Mefenamic acid—Vomiting—Dactinomycin—sarcoma	0.000329	0.00138	CcSEcCtD
Mefenamic acid—Rash—Thiotepa—sarcoma	0.000329	0.00138	CcSEcCtD
Mefenamic acid—Dermatitis—Thiotepa—sarcoma	0.000329	0.00138	CcSEcCtD
Mefenamic acid—Headache—Thiotepa—sarcoma	0.000327	0.00137	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000327	0.00137	CcSEcCtD
Mefenamic acid—Rash—Dactinomycin—sarcoma	0.000326	0.00137	CcSEcCtD
Mefenamic acid—Decreased appetite—Etoposide—sarcoma	0.000326	0.00137	CcSEcCtD
Mefenamic acid—Pancytopenia—Doxorubicin—sarcoma	0.000325	0.00136	CcSEcCtD
Mefenamic acid—Renal failure—Epirubicin—sarcoma	0.000324	0.00136	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Etoposide—sarcoma	0.000324	0.00136	CcSEcCtD
Mefenamic acid—Asthenia—Mitoxantrone—sarcoma	0.000323	0.00136	CcSEcCtD
Mefenamic acid—Jaundice—Epirubicin—sarcoma	0.000321	0.00135	CcSEcCtD
Mefenamic acid—Stomatitis—Epirubicin—sarcoma	0.000321	0.00135	CcSEcCtD
Mefenamic acid—Constipation—Etoposide—sarcoma	0.00032	0.00135	CcSEcCtD
Mefenamic acid—Conjunctivitis—Epirubicin—sarcoma	0.00032	0.00134	CcSEcCtD
Mefenamic acid—Dysuria—Doxorubicin—sarcoma	0.00032	0.00134	CcSEcCtD
Mefenamic acid—Diarrhoea—Vincristine—sarcoma	0.000317	0.00133	CcSEcCtD
Mefenamic acid—Haematuria—Epirubicin—sarcoma	0.000314	0.00132	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Doxorubicin—sarcoma	0.000312	0.00131	CcSEcCtD
Mefenamic acid—Nausea—Thiotepa—sarcoma	0.00031	0.0013	CcSEcCtD
Mefenamic acid—Feeling abnormal—Etoposide—sarcoma	0.000309	0.0013	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Doxorubicin—sarcoma	0.000308	0.00129	CcSEcCtD
Mefenamic acid—Diarrhoea—Mitoxantrone—sarcoma	0.000308	0.00129	CcSEcCtD
Mefenamic acid—Nausea—Dactinomycin—sarcoma	0.000308	0.00129	CcSEcCtD
Mefenamic acid—Agranulocytosis—Epirubicin—sarcoma	0.000307	0.00129	CcSEcCtD
Mefenamic acid—Pneumonia—Doxorubicin—sarcoma	0.000307	0.00129	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Etoposide—sarcoma	0.000306	0.00129	CcSEcCtD
Mefenamic acid—Dizziness—Vincristine—sarcoma	0.000306	0.00128	CcSEcCtD
Mefenamic acid—Drowsiness—Doxorubicin—sarcoma	0.000305	0.00128	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000302	0.00127	CcSEcCtD
Mefenamic acid—Renal failure—Doxorubicin—sarcoma	0.0003	0.00126	CcSEcCtD
Mefenamic acid—Urticaria—Etoposide—sarcoma	0.000298	0.00125	CcSEcCtD
Mefenamic acid—Haemoglobin—Epirubicin—sarcoma	0.000297	0.00125	CcSEcCtD
Mefenamic acid—Jaundice—Doxorubicin—sarcoma	0.000297	0.00125	CcSEcCtD
Mefenamic acid—Stomatitis—Doxorubicin—sarcoma	0.000297	0.00125	CcSEcCtD
Mefenamic acid—Body temperature increased—Etoposide—sarcoma	0.000296	0.00124	CcSEcCtD
Mefenamic acid—Abdominal pain—Etoposide—sarcoma	0.000296	0.00124	CcSEcCtD
Mefenamic acid—Conjunctivitis—Doxorubicin—sarcoma	0.000296	0.00124	CcSEcCtD
Mefenamic acid—Hepatitis—Epirubicin—sarcoma	0.000296	0.00124	CcSEcCtD
Mefenamic acid—Haemorrhage—Epirubicin—sarcoma	0.000296	0.00124	CcSEcCtD
Mefenamic acid—Vomiting—Vincristine—sarcoma	0.000294	0.00123	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Epirubicin—sarcoma	0.000292	0.00123	CcSEcCtD
Mefenamic acid—Rash—Vincristine—sarcoma	0.000292	0.00122	CcSEcCtD
Mefenamic acid—Dermatitis—Vincristine—sarcoma	0.000291	0.00122	CcSEcCtD
Mefenamic acid—Haematuria—Doxorubicin—sarcoma	0.000291	0.00122	CcSEcCtD
Mefenamic acid—Urethral disorder—Epirubicin—sarcoma	0.00029	0.00122	CcSEcCtD
Mefenamic acid—Headache—Vincristine—sarcoma	0.00029	0.00122	CcSEcCtD
Mefenamic acid—Vomiting—Mitoxantrone—sarcoma	0.000286	0.0012	CcSEcCtD
Mefenamic acid—Agranulocytosis—Doxorubicin—sarcoma	0.000284	0.00119	CcSEcCtD
Mefenamic acid—Rash—Mitoxantrone—sarcoma	0.000284	0.00119	CcSEcCtD
Mefenamic acid—Dermatitis—Mitoxantrone—sarcoma	0.000284	0.00119	CcSEcCtD
Mefenamic acid—Headache—Mitoxantrone—sarcoma	0.000282	0.00119	CcSEcCtD
Mefenamic acid—Erythema multiforme—Epirubicin—sarcoma	0.00028	0.00117	CcSEcCtD
Mefenamic acid—Tinnitus—Epirubicin—sarcoma	0.000276	0.00116	CcSEcCtD
Mefenamic acid—Haemoglobin—Doxorubicin—sarcoma	0.000275	0.00115	CcSEcCtD
Mefenamic acid—Nausea—Vincristine—sarcoma	0.000275	0.00115	CcSEcCtD
Mefenamic acid—Hepatitis—Doxorubicin—sarcoma	0.000274	0.00115	CcSEcCtD
Mefenamic acid—Haemorrhage—Doxorubicin—sarcoma	0.000274	0.00115	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Doxorubicin—sarcoma	0.00027	0.00113	CcSEcCtD
Mefenamic acid—Asthenia—Etoposide—sarcoma	0.000269	0.00113	CcSEcCtD
Mefenamic acid—Urethral disorder—Doxorubicin—sarcoma	0.000268	0.00113	CcSEcCtD
Mefenamic acid—Nausea—Mitoxantrone—sarcoma	0.000268	0.00112	CcSEcCtD
Mefenamic acid—Pruritus—Etoposide—sarcoma	0.000265	0.00111	CcSEcCtD
Mefenamic acid—Arrhythmia—Epirubicin—sarcoma	0.000264	0.00111	CcSEcCtD
Mefenamic acid—Alopecia—Epirubicin—sarcoma	0.000261	0.0011	CcSEcCtD
Mefenamic acid—Mental disorder—Epirubicin—sarcoma	0.000259	0.00109	CcSEcCtD
Mefenamic acid—Erythema multiforme—Doxorubicin—sarcoma	0.000259	0.00109	CcSEcCtD
Mefenamic acid—Diarrhoea—Etoposide—sarcoma	0.000256	0.00108	CcSEcCtD
Mefenamic acid—Tinnitus—Doxorubicin—sarcoma	0.000255	0.00107	CcSEcCtD
Mefenamic acid—Flatulence—Epirubicin—sarcoma	0.000254	0.00106	CcSEcCtD
Mefenamic acid—Tension—Epirubicin—sarcoma	0.000253	0.00106	CcSEcCtD
Mefenamic acid—Nervousness—Epirubicin—sarcoma	0.00025	0.00105	CcSEcCtD
Mefenamic acid—Dizziness—Etoposide—sarcoma	0.000248	0.00104	CcSEcCtD
Mefenamic acid—Arrhythmia—Doxorubicin—sarcoma	0.000244	0.00103	CcSEcCtD
Mefenamic acid—Vision blurred—Epirubicin—sarcoma	0.000243	0.00102	CcSEcCtD
Mefenamic acid—Alopecia—Doxorubicin—sarcoma	0.000242	0.00102	CcSEcCtD
Mefenamic acid—Mental disorder—Doxorubicin—sarcoma	0.00024	0.00101	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Epirubicin—sarcoma	0.000239	0.001	CcSEcCtD
Mefenamic acid—Vomiting—Etoposide—sarcoma	0.000238	0.001	CcSEcCtD
Mefenamic acid—Anaemia—Epirubicin—sarcoma	0.000238	0.000999	CcSEcCtD
Mefenamic acid—Rash—Etoposide—sarcoma	0.000236	0.000992	CcSEcCtD
Mefenamic acid—Dermatitis—Etoposide—sarcoma	0.000236	0.000991	CcSEcCtD
Mefenamic acid—Headache—Etoposide—sarcoma	0.000235	0.000986	CcSEcCtD
Mefenamic acid—Flatulence—Doxorubicin—sarcoma	0.000235	0.000985	CcSEcCtD
Mefenamic acid—Tension—Doxorubicin—sarcoma	0.000234	0.000981	CcSEcCtD
Mefenamic acid—Malaise—Epirubicin—sarcoma	0.000232	0.000975	CcSEcCtD
Mefenamic acid—Nervousness—Doxorubicin—sarcoma	0.000231	0.000971	CcSEcCtD
Mefenamic acid—Vertigo—Epirubicin—sarcoma	0.000231	0.000971	CcSEcCtD
Mefenamic acid—Syncope—Epirubicin—sarcoma	0.000231	0.000969	CcSEcCtD
Mefenamic acid—Leukopenia—Epirubicin—sarcoma	0.00023	0.000967	CcSEcCtD
Mefenamic acid—Palpitations—Epirubicin—sarcoma	0.000227	0.000955	CcSEcCtD
Mefenamic acid—Loss of consciousness—Epirubicin—sarcoma	0.000226	0.00095	CcSEcCtD
Mefenamic acid—Vision blurred—Doxorubicin—sarcoma	0.000224	0.000942	CcSEcCtD
Mefenamic acid—Convulsion—Epirubicin—sarcoma	0.000223	0.000936	CcSEcCtD
Mefenamic acid—Nausea—Etoposide—sarcoma	0.000223	0.000935	CcSEcCtD
Mefenamic acid—Hypertension—Epirubicin—sarcoma	0.000222	0.000933	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Doxorubicin—sarcoma	0.000221	0.000928	CcSEcCtD
Mefenamic acid—Anaemia—Doxorubicin—sarcoma	0.00022	0.000924	CcSEcCtD
Mefenamic acid—Anxiety—Epirubicin—sarcoma	0.000218	0.000917	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000218	0.000914	CcSEcCtD
Mefenamic acid—Discomfort—Epirubicin—sarcoma	0.000217	0.000909	CcSEcCtD
Mefenamic acid—Malaise—Doxorubicin—sarcoma	0.000215	0.000902	CcSEcCtD
Mefenamic acid—Dry mouth—Epirubicin—sarcoma	0.000214	0.0009	CcSEcCtD
Mefenamic acid—Vertigo—Doxorubicin—sarcoma	0.000214	0.000898	CcSEcCtD
Mefenamic acid—Syncope—Doxorubicin—sarcoma	0.000214	0.000897	CcSEcCtD
Mefenamic acid—Leukopenia—Doxorubicin—sarcoma	0.000213	0.000895	CcSEcCtD
Mefenamic acid—Confusional state—Epirubicin—sarcoma	0.000212	0.000889	CcSEcCtD
Mefenamic acid—Palpitations—Doxorubicin—sarcoma	0.00021	0.000884	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Epirubicin—sarcoma	0.00021	0.000882	CcSEcCtD
Mefenamic acid—Oedema—Epirubicin—sarcoma	0.00021	0.000882	CcSEcCtD
Mefenamic acid—Loss of consciousness—Doxorubicin—sarcoma	0.000209	0.000879	CcSEcCtD
Mefenamic acid—Infection—Epirubicin—sarcoma	0.000209	0.000876	CcSEcCtD
Mefenamic acid—Shock—Epirubicin—sarcoma	0.000207	0.000868	CcSEcCtD
Mefenamic acid—Convulsion—Doxorubicin—sarcoma	0.000206	0.000866	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Epirubicin—sarcoma	0.000206	0.000864	CcSEcCtD
Mefenamic acid—Hypertension—Doxorubicin—sarcoma	0.000206	0.000863	CcSEcCtD
Mefenamic acid—Tachycardia—Epirubicin—sarcoma	0.000205	0.000861	CcSEcCtD
Mefenamic acid—Skin disorder—Epirubicin—sarcoma	0.000204	0.000857	CcSEcCtD
Mefenamic acid—Anxiety—Doxorubicin—sarcoma	0.000202	0.000848	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000201	0.000845	CcSEcCtD
Mefenamic acid—Discomfort—Doxorubicin—sarcoma	0.0002	0.000841	CcSEcCtD
Mefenamic acid—Anorexia—Epirubicin—sarcoma	0.0002	0.000841	CcSEcCtD
Mefenamic acid—Dry mouth—Doxorubicin—sarcoma	0.000198	0.000833	CcSEcCtD
Mefenamic acid—Hypotension—Epirubicin—sarcoma	0.000196	0.000824	CcSEcCtD
Mefenamic acid—Confusional state—Doxorubicin—sarcoma	0.000196	0.000823	CcSEcCtD
Mefenamic acid—Oedema—Doxorubicin—sarcoma	0.000194	0.000816	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Doxorubicin—sarcoma	0.000194	0.000816	CcSEcCtD
Mefenamic acid—Infection—Doxorubicin—sarcoma	0.000193	0.000811	CcSEcCtD
Mefenamic acid—Shock—Doxorubicin—sarcoma	0.000191	0.000803	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Doxorubicin—sarcoma	0.00019	0.000799	CcSEcCtD
Mefenamic acid—Insomnia—Epirubicin—sarcoma	0.00019	0.000798	CcSEcCtD
Mefenamic acid—Tachycardia—Doxorubicin—sarcoma	0.00019	0.000796	CcSEcCtD
Mefenamic acid—Skin disorder—Doxorubicin—sarcoma	0.000189	0.000793	CcSEcCtD
Mefenamic acid—Paraesthesia—Epirubicin—sarcoma	0.000189	0.000792	CcSEcCtD
Mefenamic acid—Dyspnoea—Epirubicin—sarcoma	0.000187	0.000786	CcSEcCtD
Mefenamic acid—Somnolence—Epirubicin—sarcoma	0.000187	0.000784	CcSEcCtD
Mefenamic acid—Anorexia—Doxorubicin—sarcoma	0.000185	0.000778	CcSEcCtD
Mefenamic acid—Dyspepsia—Epirubicin—sarcoma	0.000185	0.000776	CcSEcCtD
Mefenamic acid—Decreased appetite—Epirubicin—sarcoma	0.000183	0.000767	CcSEcCtD
Mefenamic acid—Hypotension—Doxorubicin—sarcoma	0.000182	0.000763	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Epirubicin—sarcoma	0.000181	0.000761	CcSEcCtD
Mefenamic acid—Constipation—Epirubicin—sarcoma	0.00018	0.000754	CcSEcCtD
Mefenamic acid—Insomnia—Doxorubicin—sarcoma	0.000176	0.000738	CcSEcCtD
Mefenamic acid—Paraesthesia—Doxorubicin—sarcoma	0.000175	0.000733	CcSEcCtD
Mefenamic acid—Dyspnoea—Doxorubicin—sarcoma	0.000173	0.000728	CcSEcCtD
Mefenamic acid—Feeling abnormal—Epirubicin—sarcoma	0.000173	0.000727	CcSEcCtD
Mefenamic acid—Somnolence—Doxorubicin—sarcoma	0.000173	0.000725	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Epirubicin—sarcoma	0.000172	0.000721	CcSEcCtD
Mefenamic acid—Dyspepsia—Doxorubicin—sarcoma	0.000171	0.000718	CcSEcCtD
Mefenamic acid—Decreased appetite—Doxorubicin—sarcoma	0.000169	0.000709	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000168	0.000705	CcSEcCtD
Mefenamic acid—Urticaria—Epirubicin—sarcoma	0.000167	0.000701	CcSEcCtD
Mefenamic acid—Constipation—Doxorubicin—sarcoma	0.000166	0.000698	CcSEcCtD
Mefenamic acid—Body temperature increased—Epirubicin—sarcoma	0.000166	0.000697	CcSEcCtD
Mefenamic acid—Abdominal pain—Epirubicin—sarcoma	0.000166	0.000697	CcSEcCtD
Mefenamic acid—Feeling abnormal—Doxorubicin—sarcoma	0.00016	0.000672	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Doxorubicin—sarcoma	0.000159	0.000667	CcSEcCtD
Mefenamic acid—Urticaria—Doxorubicin—sarcoma	0.000154	0.000648	CcSEcCtD
Mefenamic acid—Abdominal pain—Doxorubicin—sarcoma	0.000154	0.000645	CcSEcCtD
Mefenamic acid—Body temperature increased—Doxorubicin—sarcoma	0.000154	0.000645	CcSEcCtD
Mefenamic acid—Asthenia—Epirubicin—sarcoma	0.000151	0.000633	CcSEcCtD
Mefenamic acid—Pruritus—Epirubicin—sarcoma	0.000149	0.000624	CcSEcCtD
Mefenamic acid—Diarrhoea—Epirubicin—sarcoma	0.000144	0.000603	CcSEcCtD
Mefenamic acid—Asthenia—Doxorubicin—sarcoma	0.000139	0.000586	CcSEcCtD
Mefenamic acid—Dizziness—Epirubicin—sarcoma	0.000139	0.000583	CcSEcCtD
Mefenamic acid—Pruritus—Doxorubicin—sarcoma	0.000138	0.000577	CcSEcCtD
Mefenamic acid—Vomiting—Epirubicin—sarcoma	0.000134	0.000561	CcSEcCtD
Mefenamic acid—Diarrhoea—Doxorubicin—sarcoma	0.000133	0.000558	CcSEcCtD
Mefenamic acid—Rash—Epirubicin—sarcoma	0.000132	0.000556	CcSEcCtD
Mefenamic acid—Dermatitis—Epirubicin—sarcoma	0.000132	0.000556	CcSEcCtD
Mefenamic acid—Headache—Epirubicin—sarcoma	0.000132	0.000553	CcSEcCtD
Mefenamic acid—Dizziness—Doxorubicin—sarcoma	0.000129	0.00054	CcSEcCtD
Mefenamic acid—Nausea—Epirubicin—sarcoma	0.000125	0.000524	CcSEcCtD
Mefenamic acid—Vomiting—Doxorubicin—sarcoma	0.000124	0.000519	CcSEcCtD
Mefenamic acid—Rash—Doxorubicin—sarcoma	0.000123	0.000515	CcSEcCtD
Mefenamic acid—Dermatitis—Doxorubicin—sarcoma	0.000122	0.000514	CcSEcCtD
Mefenamic acid—Headache—Doxorubicin—sarcoma	0.000122	0.000511	CcSEcCtD
Mefenamic acid—Nausea—Doxorubicin—sarcoma	0.000115	0.000485	CcSEcCtD
